PPSV 23
Alternative Names: PPSV-23Latest Information Update: 24 Oct 2023
At a glance
- Originator AIM Vaccine
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Pneumococcal infections
Most Recent Events
- 08 Sep 2023 Phase-III clinical trials in Pneumococcal infections (Prevention, In children, In adolescents, In adults, In the elderly) in China (Parenteral) (NCT06044077)